Epidemiology of cardiovascular complications in type 2 diabetes mellitus

被引：55

作者：

Meigs, JB ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA

来源：

ACTA DIABETOLOGICA | 2003年 / 40卷 / Suppl 2期

关键词：

epidemiology; risk factors; type; 2; diabetes; cardiovascular disease; insulin resistance; prevention;

D O I：

10.1007/s00592-003-0120-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 2 diabetes is increasing in epidemic proportions worldwide, and is strongly associated with atherosclerotic cardiovascular disease (CVD). Hyperglycaemia increases risk of CVD, but glycaemic control does not substantially reduce CVD risk. There are several potential explanations for this apparent paradox, including the roles of the metabolic syndrome and post-load hyperglycaemia in the association of type 2 diabetes and CVD.

引用

页码：S358 / S361

页数：4

共 30 条

[1] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2] 2-S
[3] BLAKE DR, 2003, IN PRESS DIABETES
[4] Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria
Borch-Johnsen, K
Neil, A
Balkau, B
Larsen, S
Nissinen, A
Pekkanen, J
Tuomilehto, J
Jousilahti, P
Lindstrom, J
Pyörälä, M
Pyörälä, K
Eschwege, E
Gallus, G
Garancini, MP
Bouter, LM
Dekker, JM
Heine, RJ
Nijpels, HG
Stehouwer, CDA
Feskens, EJM
Kromhout, D
Peltonen, M
Pajak, A
Eriksson, J
Qiao, Q
[J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) : 397 - 405
[5] Projection of diabetes burden through 2050 - Impact of changing demography and disease prevalence in the US
Boyle, JP
Honeycutt, AA
Narayan, KMV
Hoerger, TJ
Geiss, LS
Chen, H
Thompson, TJ
[J]. DIABETES CARE, 2001, 24 (11) : 1936 - 1940
[6] Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
Braunwald, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) : 1360 - 1369
[7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Cleeman, JI
Grundy, SM
Becker, D
Clark, LT
Cooper, RS
Denke, MA
Howard, WJ
Hunninghake, DB
Illingworth, DR
Luepker, RV
McBride, P
McKenney, JM
Pasternak, RC
Stone, NJ
Van Horn, L
Brewer, HB
Ernst, ND
Gordon, D
Levy, D
Rifkind, B
Rossouw, JE
Savage, P
Haffner, SM
Orloff, DG
Proschan, MA
Schwartz, JS
Sempos, CT
Shero, ST
Murray, EZ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
[8] PROSPECTIVE ANALYSIS OF THE INSULIN-RESISTANCE SYNDROME (SYNDROME-X)
HAFFNER, SM
VALDEZ, RA
HAZUDA, HP
MITCHELL, BD
MORALES, PA
STERN, MP
[J]. DIABETES, 1992, 41 (06) : 715 - 722
[9] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
Haffner, SM
Lehto, S
Rönnemaa, T
Pyörälä, K
Laakso, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) : 229 - 234
[10] Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes
Hu, FB
Stampfer, MJ
Haffner, SM
Solomon, CG
Willett, WC
Manson, JE
[J]. DIABETES CARE, 2002, 25 (07) : 1129 - 1134

← 1 2 3 →